These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34115398)

  • 1. Cell-Penetrating Mitochondrion-Targeting Ligands for the Universal Delivery of Small Molecules, Proteins and Nanomaterials.
    Xiao Q; Du W; Dong X; Du S; Ong SY; Tang G; Zhang C; Yang F; Li L; Gao L; Yao SQ
    Chemistry; 2021 Aug; 27(47):12207-12214. PubMed ID: 34115398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered Cell-Penetrating Peptides for Mitochondrion-Targeted Drug Delivery in Cancer Therapy.
    Xiao Q; Dong X; Yang F; Zhou S; Xiang M; Lou L; Yao SQ; Gao L
    Chemistry; 2021 Oct; 27(59):14721-14729. PubMed ID: 34436802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Peptidic Cell-Penetrating Motifs for Mitochondrion-Specific Cargo Delivery.
    Appiah Kubi G; Qian Z; Amiar S; Sahni A; Stahelin RV; Pei D
    Angew Chem Int Ed Engl; 2018 Dec; 57(52):17183-17188. PubMed ID: 30376611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating and mitochondrion-targeting molecules.
    Appiah Kubi G; Pei D
    Methods Enzymol; 2020; 641():311-328. PubMed ID: 32713527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial transit peptide exhibits cell penetration ability and efficiently delivers macromolecules to mitochondria.
    Jain A; Chugh A
    FEBS Lett; 2016 Sep; 590(17):2896-905. PubMed ID: 27461847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular delivery of noncovalently-associated macromolecules by cell-penetrating peptides.
    Chang M; Huang YW; Aronstam RS; Lee HJ
    Curr Pharm Biotechnol; 2014; 15(3):267-75. PubMed ID: 24938892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.
    Battogtokh G; Cho YY; Lee JY; Lee HS; Kang HC
    Front Pharmacol; 2018; 9():922. PubMed ID: 30174604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cell-penetrating peptide targeting mitochondria.
    Cerrato CP; Pirisinu M; Vlachos EN; Langel Ü
    FASEB J; 2015 Nov; 29(11):4589-99. PubMed ID: 26195590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of nucleic acids and nanomaterials by cell-penetrating peptides: opportunities and challenges.
    Huang YW; Lee HJ; Tolliver LM; Aronstam RS
    Biomed Res Int; 2015; 2015():834079. PubMed ID: 25883975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Targeted Gene Silencing Facilitated by Mito-CPDs.
    Lang W; Tan W; Zhou B; Zhuang Y; Zhang B; Jiang L; Yao SQ; Ge J
    Chemistry; 2023 May; 29(26):e202204021. PubMed ID: 36806226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria-Targeting, Intracellular Delivery of Native Proteins Using Biodegradable Silica Nanoparticles.
    Yuan P; Mao X; Wu X; Liew SS; Li L; Yao SQ
    Angew Chem Int Ed Engl; 2019 Jun; 58(23):7657-7661. PubMed ID: 30994955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption.
    Horton KL; Pereira MP; Stewart KM; Fonseca SB; Kelley SO
    Chembiochem; 2012 Feb; 13(3):476-85. PubMed ID: 22238158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria-targeted drug delivery system for cancer treatment.
    Chen ZP; Li M; Zhang LJ; He JY; Wu L; Xiao YY; Duan JA; Cai T; Li WD
    J Drug Target; 2016; 24(6):492-502. PubMed ID: 26548930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Targeting mitochondria: innovation from mitochondrial drug delivery system (DDS) to mitochondrial medicine].
    Yamada Y; Harashima H
    Yakugaku Zasshi; 2012; 132(10):1111-8. PubMed ID: 23037696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
    Lee YH; Park HI; Chang WS; Choi JS
    Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity.
    Yamada Y; Munechika R; Kawamura E; Sakurai Y; Sato Y; Harashima H
    J Pharm Sci; 2017 Sep; 106(9):2428-2437. PubMed ID: 28478130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.
    S Allemailem K; Almatroudi A; Alsahli MA; Aljaghwani A; M El-Kady A; Rahmani AH; Khan AA
    Int J Nanomedicine; 2021; 16():3907-3936. PubMed ID: 34135584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mitochondrial RNA Aptamer Synergistically Facilitates Cellular Uptake and Mitochondrial Targeting.
    Yamada Y; Furukawa R; Harashima H
    J Pharm Sci; 2016 May; 105(5):1705-1713. PubMed ID: 27056631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
    Xiang Y; Shan W; Huang Y
    Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.